[1]金 凤,肖 萌.血管性痴呆合并甲状腺功能减退发生率的研究[J].医学信息,2018,31(21):106-108.[doi:10.3969/j.issn.1006-1959.2018.21.029]
　JIN Feng,XIAO Meng.Study on the Incidence of Vascular Dementia Complicated with Hypothyroidism[J].Journal of Medical Information,2018,31(21):106-108.[doi:10.3969/j.issn.1006-1959.2018.21.029]
点击复制

血管性痴呆合并甲状腺功能减退发生率的研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年21期
页码:
106-108
栏目:
临床研究
出版日期:
2018-11-01

文章信息/Info

Title:
Study on the Incidence of Vascular Dementia Complicated with Hypothyroidism
文章编号:
1006-1959（2018）21-0106-03
作者:
金 凤; 肖 萌
新疆精神卫生中心/乌鲁木齐市第四人民医院急诊科，新疆 乌鲁木齐 830002
Author(s):
JIN Feng; XIAO Meng
Xinjiang Mental Health Center/Department of Emergency,the Fourth People's Hospital of Urumqi, Urumqi 830002,Xinjiang,China
关键词:
血管性痴呆; 甲状腺功能减退; FT3; FT4; TSH
Keywords:
vascular dementia;  hypothyroidism;  FT3;  FT4;  TSH
分类号:
R749.13；R581.2
DOI:
10.3969/j.issn.1006-1959.2018.21.029
文献标志码:
A
摘要:
目的 探讨血管性痴呆患者合并甲状腺功能减退的几率是否较其他人群升高。方法 选取2014年12月~2016年12月我院收治的100例血管性痴呆患者为VD组，同时收集100例年龄匹配智力正常人群作为对照组，对两组人群进行甲状腺功能检测，比较两组FT3、FT4、TSH检测结果以及甲状腺功能减退发生率。结果 VD组中甲状腺功能减退发生率为21.00%，高于对照组的6.00%，差异具有统计学意义（P＜0.05）。VD组FT3和FT4水平分别为（2.85±0.55）nmol/L和（8.81±4.72）nmol/L，低于对照组的（5.31±1.25）nmol/L和（18.15±4.58）nmol/L，TSH水平为（8.14±4.43）μIU/ml，高于对照组的（2.54±1.76）μIU/ml，差异具有统计学意义（P＜0.05）。结论 血管性痴呆合并甲状腺功能减退的发生率高于正常人群。
Abstract:
Objective To investigate whether the incidence of hypothyroidism in patients with vascular dementia is higher than in other populations. Methods From December 2014 to December 2016, 100 patients with vascular dementia admitted to our hospital were selected as VD group, and 100 age-matched normal people were collected as control group. The thyroid function test was performed in the two groups. Group FT3, FT4, TSH test results and incidence of hypothyroidism.Results The incidence of hypothyroidism in the VD group was 21.00%, which was higher than that of the control group 6.00%,the difference was statistically significant (P＜0.05). The levels of FT3 and FT4 in the VD group were (2.85±0.55) nmol/L and (8.81±4.72) nmol/L, respectively, which were lower than that of the control group (5.31±1.25) nmol/L and (18.15±4.58) nmol/L, the TSH level was (8.14±4.43) μIU/ml, which was higher than that of the control group (2.54±1.76) μIU/ml,the difference was statistically significant(P<0.05). Conclusion The incidence of vascular dementia with hypothyroidism is higher than that of the normal population.

参考文献/References:

[1]单忠艳.成人甲状腺功能减退症临床处理指南实践心得[J].中国实用内科杂志,2014,34(4):344-346. [2]谌剑飞.甲状腺功能亢进症合并脑梗死的临床研究[J].中西医结合心脑血管病杂志,2011,9(11):1322-1323. [3]张颖,姚旋.甲状腺激素与代谢调控[J].生命科学,2013,25(2):176-183. [4]贾志荣.脑梗死性痴呆影响因素的临床研究[J].临床神经病学杂志,2014,27(4):216-217. [5]樊亚超,王海峰,王新,等.缺血性脑小血管病患者轻度认知障碍的危险因素和临床特征:回顾性病例系列研究[J].国际脑血管病杂志,2012,20(08):564-569. [6]雷宇,郭起浩,李彦江,等.成人缺血性脑血管病的认知损害特征分析[J].中华医学杂志,2014,94(13):984-989. [7]刘菊,陈红旗.以神经系统症状为首发的甲状腺功能减退症临床分析[J].中国实用神经疾病杂志,2014,17(5):92-93. [8]刘小莲,邱文,梁秋波,等.甲状腺功能减退症妇女子代的甲状腺功能、智力和身体发育的研究[J].中国医学创新,2012,9(1):6-8. [9]李鸿梅.缺血性脑卒中后血管性痴呆的影响因素分析临床研究[J].中国医药导报,2015,12(1):48-49.

相似文献/References:

[1]李雨芹,黄顺贵,王思迅,等.醒脑静注射液辅助治疗血管性痴呆的疗效的Meta分析[J].医学信息,2018,31(11):84.[doi:10.3969/j.issn.1006-1959.2018.11.026]
　LI Yu-qin,HUANG Shun-gui,WANG Si-xun,et al.Meta Analysis of Efficacy of Xingnaojing Injection in Adjuvant Treatment of Vascular Dementia[J].Journal of Medical Information,2018,31(21):84.[doi:10.3969/j.issn.1006-1959.2018.11.026]
[2]赵 钟.针灸治疗血管性痴呆的研究[J].医学信息,2022,35(15):175.[doi:10.3969/j.issn.1006-1959.2022.15.042]
　ZHAO Zhong.Study on Acupuncture Treatment of Vascular Dementia[J].Journal of Medical Information,2022,35(21):175.[doi:10.3969/j.issn.1006-1959.2022.15.042]
[3]张 晶.血清TSH和Hcy测定在甲状腺功能减退诊断中的价值[J].医学信息,2020,33(01):165.[doi:10.3969/j.issn.1006-1959.2020.01.054]
　ZHANG Jing.The Role of Serum TSH and Hcy in the Diagnosis of Hypothyroidism[J].Journal of Medical Information,2020,33(21):165.[doi:10.3969/j.issn.1006-1959.2020.01.054]
[4]李雨芹,刘 梅.石杉碱甲联合尼莫地平治疗血管性痴呆疗效与安全性的Meta分析[J].医学信息,2020,33(11):82.[doi:10.3969/j.issn.1006-1959.2020.11.024]
　LI Yu-qin,LIU Mei.Meta Analysis of the Efficacy and Safety of Huperzine A Combined with Nimodipine in the Treatment of Vascular Dementia[J].Journal of Medical Information,2020,33(21):82.[doi:10.3969/j.issn.1006-1959.2020.11.024]
[5]王教香.妊娠期甲状腺功能减退对胎儿及妊娠结局的影响及防治[J].医学信息,2020,33(20):42.[doi:10.3969/j.issn.1006-1959.2020.20.012]
　WANG Jiao-xiang.The Influence of Hypothyroidism During Pregnancy on the Fetus and Pregnancy Outcome and Its Prevention[J].Journal of Medical Information,2020,33(21):42.[doi:10.3969/j.issn.1006-1959.2020.20.012]
[6]索 艳,王 肃.甲状腺疾病与代谢综合征关系的研究[J].医学信息,2022,35(04):53.[doi:10.3969/j.issn.1006-1959.2022.04.014]
　SUO Yan,WANG Su.Study on the Relationship Between Thyroid Diseases and Metabolic Syndrome[J].Journal of Medical Information,2022,35(21):53.[doi:10.3969/j.issn.1006-1959.2022.04.014]
[7]晏艳平,许小兵,刘敏鹃.安神益智针法联合电刺激对血管性痴呆患者的认知功能、氧自由基及IL-6的影响[J].医学信息,2023,36(18):94.[doi:10.3969/j.issn.1006-1959.2023.18.017]
　YAN Yan-ping,XU Xiao-bing,LIU Min-juan.Effects of Anshen Yizhi Acupuncture Combined with Electrical Stimulation on Cognitive Function,Oxygen Free Radical and IL-6 in Patients with Vascular Dementia[J].Journal of Medical Information,2023,36(21):94.[doi:10.3969/j.issn.1006-1959.2023.18.017]
[8]孙 勇.多奈哌齐联合丁苯酞治疗血管性痴呆的临床疗效及对神经功能恢复的影响[J].医学信息,2023,36(23):77.[doi:10.3969/j.issn.1006-1959.2023.23.019]
　SUN Yong.Clinical Efficacy of Donepezil Combined with Butylphthalide in the Treatment of Vascular Dementia and its Effect on the Recovery of Neurological Function[J].Journal of Medical Information,2023,36(21):77.[doi:10.3969/j.issn.1006-1959.2023.23.019]

更新日期/Last Update: 2018-11-20